Diagnoses genes predispose breast and ovarian cancer genes brca2. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Breast Cell Line, Tumor Tumor Cells, Cultured Ovary Epithelial Cells Neoplastic Stem Cells MCF-7 Cells Chromosomes, Human, Pair 17 Cell Line Mammary Glands, Human

Organisms4

Mice, Nude Adenoviridae Mice, SCID Mice, Inbred BALB C

Diseases51

Ovarian Neoplasms Breast Neoplasms Neoplasms, Glandular and Epithelial Genetic Predisposition to Disease Carcinoma, Ductal, Breast Neoplasms Breast Diseases Cystadenocarcinoma, Serous Carcinoma Neoplasm Invasiveness Breast Neoplasms, Male Neoplasm Metastasis Prostatic Neoplasms Lung Neoplasms Neoplastic Syndromes, Hereditary Disease Progression Adenocarcinoma, Clear Cell Colonic Neoplasms Adenocarcinoma, Mucinous Neoplasm Recurrence, Local Peritoneal Neoplasms Carcinoma, Endometrioid Adenocarcinoma Cell Transformation, Neoplastic Pancreatic Neoplasms Ascites Stomach Neoplasms Fallopian Tube Neoplasms Fibrocystic Breast Disease Colorectal Neoplasms Carcinoma, Intraductal, Noninfiltrating Endometrial Neoplasms Mammary Neoplasms, Experimental Carcinoma, Lobular Cystadenocarcinoma Uterine Cervical Neoplasms Neovascularization, Pathologic Carcinoma, Squamous Cell Neoplasms, Hormone-Dependent Hereditary Breast and Ovarian Cancer Syndrome Neoplasms, Second Primary Gliosarcoma Neoplasms, Multiple Primary Neoplasms, Cystic, Mucinous, and Serous Genital Neoplasms, Female Chromosome Aberrations Liver Neoplasms Carcinoma in Situ Genomic Instability Bone Neoplasms Urinary Bladder Neoplasms

Chemicals and Drugs47

BRCA1 Protein BRCA2 Protein Neoplasm Proteins CA-125 Antigen Tumor Markers, Biological Rad51 Recombinase Transcription Factors Antineoplastic Agents Receptors, Estrogen Receptor, erbB-2 DNA, Neoplasm Cisplatin RNA, Messenger Receptors, Progesterone Paclitaxel RNA, Small Interfering Tamoxifen Tumor Suppressor Proteins Tumor Suppressor Protein p53 Antineoplastic Agents, Phytogenic Antineoplastic Agents, Hormonal DNA-Binding Proteins Carboplatin Nuclear Proteins RNA, Neoplasm Antigens, Neoplasm Prodrugs Epididymal Secretory Proteins Estrogens Antibodies, Monoclonal Cancer Vaccines MicroRNAs Estrogen Receptor alpha DNA Primers Taxoids Platinum Compounds Cyclophosphamide Proto-Oncogene Proteins Platinum Genetic Markers Receptor, Epidermal Growth Factor Thymidine Kinase Antibodies, Monoclonal, Humanized Fluorouracil Protein-Serine-Threonine Kinases Mucin-1 Antigens, Tumor-Associated, Carbohydrate

Analytical, Diagnostic and Therapeutic Techniques and Equipment77

Genetic Testing Genetic Therapy Prognosis Gene Expression Profiling Neoplasm Staging Early Detection of Cancer Sensitivity and Specificity Risk Factors Retrospective Studies Reverse Transcriptase Polymerase Chain Reaction Survival Analysis DNA Mutational Analysis Mammography Xenograft Model Antitumor Assays Immunohistochemistry Case-Control Studies Antineoplastic Combined Chemotherapy Protocols Prospective Studies Survival Rate Oligonucleotide Array Sequence Analysis Follow-Up Studies Polymerase Chain Reaction Risk Neoplasm Transplantation Disease-Free Survival Reproducibility of Results Blotting, Western Early Diagnosis Delayed Diagnosis Treatment Outcome Risk Assessment Cohort Studies Transfection Predictive Value of Tests Mastectomy Transplantation, Heterologous Incidence Odds Ratio Registries Chemotherapy, Adjuvant Multivariate Analysis Gene Transfer Techniques Pedigree Kaplan-Meier Estimate Breast Self-Examination Combined Modality Therapy Mammary Neoplasms, Experimental Prenatal Diagnosis Biopsy Tissue Array Analysis Questionnaires Neoplasm Grading Logistic Models Breast Implants Immunoenzyme Techniques Salpingectomy Tumor Burden Drug Screening Assays, Antitumor Biopsy, Needle SEER Program Confidence Intervals Models, Biological Cluster Analysis Tomography, X-Ray Computed Ultrasonography, Mammary Drug Administration Schedule Flow Cytometry In Situ Hybridization, Fluorescence Mass Screening Enzyme-Linked Immunosorbent Assay Gene Knockdown Techniques Clinical Trials as Topic Diagnosis ROC Curve Ovariectomy Molecular Targeted Therapy Mastectomy, Segmental

Psychiatry and Psychology2

Breast Feeding Breast Self-Examination

Phenomena and Processes62

Genes, BRCA1 Genes, BRCA2 Germ-Line Mutation Genes, Neoplasm Mutation Genetic Predisposition to Disease Heterozygote Gene Expression Regulation, Neoplastic DNA Repair DNA Damage Sensitivity and Specificity Drug Resistance, Neoplasm Breast Feeding Genetic Vectors Cell Proliferation Apoptosis Risk Genes, Tumor Suppressor Time Factors DNA Methylation Promoter Regions, Genetic Transfection Genotype Signal Transduction Oncogenes Odds Ratio Cell Division Cell Cycle Genes, Transgenic, Suicide Base Sequence Gene Silencing RNA Interference Genes, p53 Gene Expression Founder Effect Down-Regulation Polymorphism, Genetic Postmenopause Cell Survival Phenotype Loss of Heterozygosity Alleles Cell Movement Dose-Response Relationship, Drug Exons Menopause Algorithms Gene Amplification Cell Growth Processes Up-Regulation Premenopause Genome, Human Chromosomes, Human, Pair 17 Polymorphism, Single Nucleotide Gene Regulatory Networks Genetic Markers Chromosome Aberrations Parity Genomic Instability Gene Dosage Genes, erbB-2 Transcription, Genetic

Disciplines and Occupations5

Immunohistochemistry Genetic Counseling Genomics Medical Oncology Computational Biology

Information Science8

Survival Rate Incidence Registries Base Sequence Molecular Sequence Data Questionnaires Algorithms SEER Program

Named Groups2

Health Care33

Genetic Testing Sensitivity and Specificity Risk Factors Retrospective Studies Survival Analysis Case-Control Studies Prospective Studies Survival Rate Follow-Up Studies Risk Disease-Free Survival Reproducibility of Results Genetic Counseling Treatment Outcome Risk Assessment Age Factors Cohort Studies Predictive Value of Tests Incidence Odds Ratio Registries Multivariate Analysis Kaplan-Meier Estimate Questionnaires Logistic Models Family Health SEER Program Confidence Intervals Cluster Analysis Mass Screening Parity Clinical Trials as Topic ROC Curve

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Information Science Named Groups Health Care Geographicals

Ovarian Neoplasms BRCA1 Protein Genes, BRCA1 BRCA2 Protein Genes, BRCA2 Breast Breast Neoplasms Germ-Line Mutation Neoplasms, Glandular and Epithelial Genes, Neoplasm Neoplasm Proteins Mutation Genetic Predisposition to Disease Cell Line, Tumor Genetic Testing Heterozygote Gene Expression Regulation, Neoplastic Carcinoma, Ductal, Breast Neoplasms Breast Diseases Genetic Therapy Tumor Cells, Cultured CA-125 Antigen Cystadenocarcinoma, Serous Tumor Markers, Biological Rad51 Recombinase Prognosis Carcinoma Mice, Nude Transcription Factors Antineoplastic Agents Neoplasm Invasiveness DNA Repair Gene Expression Profiling Breast Neoplasms, Male DNA Damage Neoplasm Staging Early Detection of Cancer Neoplasm Metastasis Sensitivity and Specificity Drug Resistance, Neoplasm Receptors, Estrogen Risk Factors Prostatic Neoplasms Retrospective Studies Reverse Transcriptase Polymerase Chain Reaction Adenoviridae Receptor, erbB-2 Survival Analysis DNA, Neoplasm Breast Feeding DNA Mutational Analysis Mammography Genetic Vectors Xenograft Model Antitumor Assays Immunohistochemistry Lung Neoplasms Case-Control Studies Antineoplastic Combined Chemotherapy Protocols Neoplastic Syndromes, Hereditary Cell Proliferation Cisplatin RNA, Messenger Prospective Studies Receptors, Progesterone Survival Rate Disease Progression Apoptosis Oligonucleotide Array Sequence Analysis Follow-Up Studies Adenocarcinoma, Clear Cell Polymerase Chain Reaction Risk Genes, Tumor Suppressor Jews Neoplasm Transplantation Paclitaxel Colonic Neoplasms Adenocarcinoma, Mucinous Neoplasm Recurrence, Local Disease-Free Survival RNA, Small Interfering Reproducibility of Results Tamoxifen Genetic Counseling Peritoneal Neoplasms Blotting, Western Carcinoma, Endometrioid Early Diagnosis Delayed Diagnosis Tumor Suppressor Proteins Time Factors Treatment Outcome Risk Assessment Age Factors DNA Methylation Tumor Suppressor Protein p53 Adenocarcinoma Promoter Regions, Genetic Cohort Studies

No FAQ available that match "diagnoses genes predispose breast and ovarian cancer genes brca2"